The aim of this study is to analyze the effect of apolipoprotein E (apo E) and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms on serum lipid and homocysteine levels in the general Japanese population. Methods: We analyzed the polymorphisms in individuals randomly selected from among participants of Serum Lipid Survey 2000. Results: The frequency of the 2, 3, and 4 alleles of APOE was 4.2, 85.3, and 10.5%, respectively. Individuals with the genotype 4/ 4 had the highest total and low-density lipoprotein (LDL) cholesterol levels, while those with 2/ 2 had the lowest. Individuals with the 2/ 2 and 2/ 4 genotypes had higher remnant-like particles (RLP)-cholesterol levels than those with 2 3, 3 3, and 3 4. There was a trend for individuals with the 2/ 4 and 2/ 2 genotypes to have higher triglyceride levels, although the difference was not significant. The presence of the T allele in a MTHFR polymorphism (C667T) was associated with higher homocysteine levels, which is more prominent in men than in women. Conclusion: Thus in our large-scale analysis we have shown that RLP-cholesterol is better associated with APOE genotype than triglyceride and the effect of the T allele on MTHFR polymorphism (C667T) homocysteine levels is more prominent in men than in women among Japanese.
Introduction
Apolipoprotein E (apo E) is an important structural constituent of serum chylomicrons, very low-density lipoproteins, and high-density lipoproteins (HDL) and plays a critical role in lipoprotein metablism, where it can facilitate the clearance of remnant lipoprotein and cellular efflux of cholesterol 1) . Apo E has three polymorphisms, 2, 3, and 4, which affect lipoprotein metabolism and atherosclerosis 2) . The 4 allele is associated with higher low-density lipoprotein (LDL) cholesterol levels than the other alleles and with a higher incidence of coronary heart disease 3) . Apo E4 is also shown to be involved in the development of Alzheimer's disease 4) , while homozygosity for apo E2 is associated with the development of type hyperlipidemia 5) . We also studied the MTHFR gene because its polymorphisms affect serum homocysteine levels and homocysteine is also associated with cardiovascular disease and Alzheimer's disease [6] [7] [8] [9] . An elevated homocysteine level is associated with coronary heart disease and the C677T polymorphism in the MTHFR gene results in reduced MTHFR enzyme activity and reduced methylation of homocysteine to methioneine resulting in mild hyperhomocysteinemia 10) . Although several studies have examined the incidence of APOE and MTH-FR polymorphisms 8, 11) , these has been no large-scale study to determine the incidence of APOE and MTH-FR polymorphisms and their association with lipoprotein profiles and homocysteine levels in the general Japanese population. In 2000, we conducted a lipid survey in the Japanese population, 12,839 people all over the country. In this survey, we examined APOE and MTHFR gene polymorphisms to determine the incidence of each and its relationship with lipid profiles and homocysteine levels in the Japanese.
Methods

Design and Data Collection
This work is part of Serum Lipid Level Survey 2000 from various parts of Japan. The Ethics committee, Graduate School and Faculty of Medicine, Kyoto University approved the study protocol and all subjects provided written informed consent for participation in the gene analysis. The handling of DNA samples followed the guidelines from the Ministry of Health, Labor, and Welfare. In Serum Lipid Survey 2000, a total of 12,839 subjects were recruited at 36 hospitals across the country. The subjects in the present study were participants in the survey at 9 hospitals from whom informed content for genotyping was sought. Of the 12,839 subjects, 2,267 (17.7%) with no lipidaltering medication were randomly selected for the present study. Among the 2,267 participants, we examined serum homocysteine levels and MTHFR gene polymorphisms in 505 participants.
Laboratory Methods
All serum and blood samples were obtained in the fasting state. All lipid and other analyses were conducted on venous blood samples within one week of collection at BML (Saitama, Japan). Serum cholesterol and TG levels were measured by enzymatic assay. HDLcholesterol and LDL-cholesterol levels were measured enzymatically with a kit from Daiichi Kagaku Co. Ltd. (Tokyo, Japan). The results of lipid analyses in the four surveys were indirectly standardized according to the criteria of the CDC Lipid Standardization Program 12) . The serum homocysteine level was assayed by high performance liquid chromatography with fluorescent detection as described by Ubbink et al. 13) . DNA was extracted with a QIAamp DNA blood kit (Qiagen, Hilden, Germany).
Detection of gene Mutations by Invader
® Assay We used the Invader ® assay to screen for mutations of the APOE and MTHFR genes, as previously described. In brief, the probe/Invader 
Data Analyses
Differences in means were evaluated with an analysis of variance. The analysis was performed with the statistical Package for Social Sciences (SPSS Japan Inc. ver. 11.5, Tokyo, Japan).
Results
We investigated the frequency and phenotypic association of APOE gene polymorphisms of 2,267 subjects. We found that the SNPs were in Hardy-Weinberg equilibrium. As previously described, the mean age, total cholesterol, TG, HDL-cholesterol, and LDLcholesterol levels in this population were similar to the levels for all 12,839 patients in Serum Lipid Survey 2000 14) . We also found that the medians of total, LDL-, and HDL-cholesterol levels did not differ appreciably from the means, thereby excluding gross right-hand tailing of the distribution (data not shown). These data indicate that the participants in the gene analysis are representative of the general Japanese population.
The genotype and allelic frequency of APOE polymorphisms are presented in Table 1 . The frequency of the 2, 3, and 4 alleles was 4.2, 85.3, and 10.5%, respectively. As in other studies, the genotypes 2 2, 2 4, and 4 4 were quite rare. High frequencies of the 3 allele are also found in Chinese, but the frequency is lower in Caucasians 15) . We next examined the association of the APOE genotype and lipid profiles in these participants. As shown in Table 2 , all the lipid parameters and blood glucose differed significantly among these genotypes by ANOVA. Total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, and RLP-cholesterol levels were different among the groups. The p values are shown in the right column. According to the post-hoc analysis, the total cholesterol level was significantly lower for genotype 2 2 than 4 4 and genotype 2 3 than 3 3, 2 4, or 4 4. The HDL-cholesterol level was significantly higher for 2 3 than 2 4. The LDLcholesterol level was significantly lower for genotypes 2 2 and 2 3 than for 3 3, 3 4, and 4 4. The RLP-cholesterol level was significantly higher for 2 2 than 2 3, 3 3, 3 4, or 4 4 and for genotype 2 4 than 2 3, 3 3, or 3 4, although there was no significant difference in triglyceride levels according to the post-hoc analysis. Blood glucose or age did not differ significantly among the groups.
We next examined the association of the MTHFR C667T polymorphism with serum homocysteine levels in 505 samples randomly selected from 2,267 samples. As shown in Table 3 , the incidence of the CC, CT, and TT genotypes was 33.9, 46.1, and 20.0%, respectively. The TT genotype was significantly associated with higher homocysteine levels in men and women, and statistical significance was found between CC and TT and between CT and TT by a post-hoc analysis. However, the difference was more prominent in men.
Discussion
There, we have shown in a large-scale study, the frequency of the APOE genotype in the Japanese and its association with serum lipid levels. Frequencies of APOE genotypes are highly heterogenous among various populations. Epidemiological data indicate that the frequency of the 3 allele is higher in Japanese and Chinese than in Caucasians, while the frequency of the 4 allele is lower in Asians than Caucasians 3, 16) . Our data indicate that the frequency of the 3 allele is quite consistent with previous reports in Japanese 8, 11, 16, 17) , and is slightly higher than that of Icelandic and Hungarian populations and much higher than that in the Finnish population 15) . Our study confirmed that the 4 allele is associated with higher, and the 2 allele is associated with lower, LDL cholesterol levels. Although there was a trend for individuals with the genotypes 2/ 4 and 2/ 2 to have higher triglyceride levels, it was not statistically significant by a post-hoc analysis, probably because triglyceride levels are highly variable. However, individuals with 2/ 4 and 2/ 2 had significantly higher RLP-cholesterol levels than did those with the other genotypes, indicating that RLP-cholesterol might be better correlated with APOE genotype. Although in this study we could not compare the body mass index of 2/ 2 homozygotes, it would be intriguing to know whether individuals with the 2/ 4 and 2/ 2 genotypes have metabolic abnormalities, such as abdominal obesity and insulin resistance, because they have higher triglyceride, RLP-cholesterol, and blood glucose levels.
Elevated levels of homocysteine have been considered a risk for cardiovascular disease. Our study is consistent with other studies that show higher homocysteine levels in people with the TT genotype. However, the relationship between the C677T MTHFR polymorphism and cardiovascular disease is still controversial. Because our study population is made up of healthy volunteers, a prospective study is necessary to determine which genotype is associated with cardiovascular risk.
In summary, we have provided the largest database of gene polymorphisms related to lipid metabolism and homocysteine in the general Japanese population. A prospective study is necessary to determine the contribution of these gene polymorphisms to cardiovascular risk in Japanese. 
